{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:41:55Z","timestamp":1791614515143,"version":"4.3.4"},"reference-count":86,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2026,1,12]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the comparative effectiveness and safety of pharmacological and non-pharmacological smoking cessation interventions in people with severe mental illness<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and network meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Medline, Embase, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science, from inception to 19 September 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria for selecting studies<\/jats:title>\n                    <jats:p>Trials enrolling adults who had established diagnoses of schizophrenia, bipolar disorder, recurrent or current severe major depressive disorder, or post-traumatic stress disorder, randomised to a smoking cessation intervention versus another active treatment, placebo, standard care, or no treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>74 randomised controlled trials (11\u2009023 participants) evaluating nine smoking cessation interventions were included in the study. Compared with placebo or minimal care, varenicline (10 more per 100 achieving long term smoking abstinence, 95%\u2009confidence interval (CI) 5 to 16; high certainty evidence) and bupropion (5 more per 100, 1 to 10; moderate certainty evidence) increased long term abstinence. Effects on short term smoking abstinence were similar. Nicotine replacement therapy improved short term abstinence but with little or no long term abstinence benefit (moderate certainty evidence). Combination interventions (pharmacological with non-pharmacological interventions) may increase long term abstinence (6 more per 100, 95%\u2009CI 3 to 11; low certainty evidence). The certainty of evidence for other interventions was very low. Serious adverse event data were highly uncertain. Dropout from a trial because of harms was possibly no different for varenicline, bupropion, and nicotine replacement therapy compared with placebo or minimal care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Varenicline, bupropion, and nicotine replacement therapy likely improved smoking abstinence in people with severe mental illness compared with placebo or minimal care (moderate to high certainty evidence). Combined pharmacological and non-pharmacological approaches may offer more benefit (low certainty evidence), but the risk of serious adverse events for all interventions was very uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>PROSPERO CRD42022349498.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjmed-2025-002190","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:35:17Z","timestamp":1770906917000},"page":"e002190","source":"Crossref","is-referenced-by-count":9,"title":["Smoking cessation for people with severe mental illness: systematic review and network meta-analysis"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3845-1507","authenticated-orcid":false,"given":"Geertruida E","family":"Bekkering","sequence":"first","affiliation":[{"name":"Department of Public Health Care and Primary Care, Academic Centre of General Practice, KU Leuven, Leuven, Belgium"},{"name":"Cebam-Belgian Centre for Evidence-Based Medicine, Leuven, Belgium"},{"name":"Cochrane Belgium, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6363-3767","authenticated-orcid":false,"given":"Johan","family":"Detraux","sequence":"additional","affiliation":[{"name":"University Psychiatric Centre KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-3616","authenticated-orcid":false,"given":"Jos\u00e9 A","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Basic Psychology and Methodology, Espinardo Compus, Faculty of Psychology, University of Murcia, Murcia, Spain"},{"name":"Biomedical Research Institute of Murcia Pascual Parrilla-IMIB, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4255-5920","authenticated-orcid":false,"given":"Marc","family":"De Hert","sequence":"additional","affiliation":[{"name":"University Psychiatric Centre KU Leuven, Leuven, Belgium"},{"name":"Department of Neurosciences, Centre for Clinical Psychiatry, KU Leuven, Leuven, Belgium"},{"name":"KU Leuven, Leuven Brain Institute, Leuven, Belgium"},{"name":"Antwerp Health Law and Ethics, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Eden","family":"Evins","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Department of Psychiatry, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7899-8366","authenticated-orcid":false,"given":"Anne-Catherine","family":"Vanhove","sequence":"additional","affiliation":[{"name":"Cebam-Belgian Centre for Evidence-Based Medicine, Leuven, Belgium"},{"name":"Cochrane Belgium, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Cloetens","sequence":"additional","affiliation":[{"name":"Community Health Centre De Bruggen, Brugge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M","family":"Algarni","sequence":"additional","affiliation":[{"name":"Family Medicine Department, Aseer Central Hospital, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9980-6941","authenticated-orcid":false,"given":"Thomas","family":"Vandendriessche","sequence":"additional","affiliation":[{"name":"2Bergen, KU Leuven Libraries, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0931-7851","authenticated-orcid":false,"given":"Arnav","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Alberta, Canada"},{"name":"MAGIC Evidence Ecosystem Foundation, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6182-9969","authenticated-orcid":false,"given":"Thomas","family":"Agoritsas","sequence":"additional","affiliation":[{"name":"MAGIC Evidence Ecosystem Foundation, Oslo, Norway"},{"name":"Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada"},{"name":"Division of General Internal Medicine and Division of Epidemiology, University Hospitals of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1142-5402","authenticated-orcid":false,"given":"Bert","family":"Aertgeerts","sequence":"additional","affiliation":[{"name":"Department of Public Health Care and Primary Care, Academic Centre of General Practice, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7335-4075","authenticated-orcid":false,"given":"Nicolas","family":"Delvaux","sequence":"additional","affiliation":[{"name":"Department of Public Health Care and Primary Care, Academic Centre of General Practice, KU Leuven, Leuven, Belgium"},{"name":"Public Health and Primary Care, KU Leuven-Kulak Kortrijk Campus, Kortrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0437-6633","authenticated-orcid":false,"given":"Mieke","family":"Vermandere","sequence":"additional","affiliation":[{"name":"Panoramaweg 47, Leuven, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"2026021206350880000_5.1.e002190.1","first-page":"383","article-title":"Defining chronic mental illness: a concept paper","volume":"39","author":"Bachrach","year":"1988","journal-title":"Hosp Community Psychiatry"},{"key":"2026021206350880000_5.1.e002190.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31948-2"},{"key":"2026021206350880000_5.1.e002190.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31544-0"},{"key":"2026021206350880000_5.1.e002190.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01121-6"},{"key":"2026021206350880000_5.1.e002190.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"2026021206350880000_5.1.e002190.6","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20204"},{"key":"2026021206350880000_5.1.e002190.7","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12408"},{"key":"2026021206350880000_5.1.e002190.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.12.067"},{"key":"2026021206350880000_5.1.e002190.9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","article-title":"Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis","volume":"72","author":"Walker","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"2026021206350880000_5.1.e002190.10","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20384"},{"key":"2026021206350880000_5.1.e002190.11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"Hjorth\u00f8j","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"2026021206350880000_5.1.e002190.12","doi-asserted-by":"crossref","first-page":"573479","DOI":"10.3389\/fendo.2020.573479","article-title":"Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness","volume":"11","author":"Mazereel","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026021206350880000_5.1.e002190.13","doi-asserted-by":"publisher","DOI":"10.1002\/j.2051-5545.2011.tb00014.x"},{"key":"2026021206350880000_5.1.e002190.14","unstructured":"World Health Organization . The who special initiative for mental health (2019-2023): universal health coverage for mental health. 2019. Available: https:\/\/iris.who.int\/handle\/10665\/310981"},{"key":"2026021206350880000_5.1.e002190.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2014.11.006"},{"key":"2026021206350880000_5.1.e002190.16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/acps.12412","article-title":"How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview","volume":"132","author":"Stubbs","year":"2015","journal-title":"Acta Psychiatr Scand"},{"key":"2026021206350880000_5.1.e002190.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027389","article-title":"Pharmacological and behavioural interventions to promote smoking cessation in adults with schizophrenia and bipolar disorders: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Pearsall","year":"2019","journal-title":"BMJ Open"},{"key":"2026021206350880000_5.1.e002190.18","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-04857-3"},{"key":"2026021206350880000_5.1.e002190.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2013.09.014"},{"key":"2026021206350880000_5.1.e002190.20","unstructured":"USDoHaH S . The health consequences of smoking\u201450 years of progress: a report of the surgeon general. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. Available: https:\/\/archivecdcgov\/#\/details?url=https:\/\/wwwcdcgov\/tobacco\/sgr\/50th-anniversary\/indexhtm [Accessed 28 Feb 2024]."},{"key":"2026021206350880000_5.1.e002190.21","doi-asserted-by":"crossref","unstructured":"Sayer JSM . Smoking. In: Corrigan PB , ed. Health and wellness in people living with serious mental illness. Washington: American Psychiatric Association Publishing, 2021: 239\u201365.","DOI":"10.1176\/appi.books.9781615379774.lg11"},{"key":"2026021206350880000_5.1.e002190.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02109-9"},{"key":"2026021206350880000_5.1.e002190.23","unstructured":"SAMHSA Administration . Advisory: implementing tobacco cessation treatment for individuals with serious mental illness: a quick guide for program directors and clinicians. 2019. Available: https:\/\/store.samhsa.gov\/sites\/default\/files\/pep19-02-00-001_0.pdf"},{"key":"2026021206350880000_5.1.e002190.24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajp.2019.05.002","article-title":"Tobacco smoking and nicotine dependence in first episode and established psychosis","volume":"43","author":"Lally","year":"2019","journal-title":"Asian J Psychiatr"},{"key":"2026021206350880000_5.1.e002190.25","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21444"},{"key":"2026021206350880000_5.1.e002190.26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-285"},{"key":"2026021206350880000_5.1.e002190.27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/00048674221147206","article-title":"A systematic review of factors associated with sustained smoking abstinence in people experiencing severe mental illness following participation in a smoking intervention","volume":"57","author":"Davies","year":"2023","journal-title":"Aust N Z J Psychiatry"},{"key":"2026021206350880000_5.1.e002190.28","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.3390\/ijerph10094186","article-title":"Gold standard program for heavy smokers in a real-life setting","volume":"10","author":"Neumann","year":"2013","journal-title":"Int J Environ Res Public Health"},{"key":"2026021206350880000_5.1.e002190.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30272-0"},{"key":"2026021206350880000_5.1.e002190.30","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001015"},{"key":"2026021206350880000_5.1.e002190.31","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-017-1419-7"},{"key":"2026021206350880000_5.1.e002190.32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1192\/bjp.2019.192","article-title":"Smoking cessation in severe mental illness: combined long-term quit rates from the UK SCIMITAR trials programme","volume":"218","author":"Gilbody","year":"2021","journal-title":"Br J Psychiatry"},{"key":"2026021206350880000_5.1.e002190.33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S2215-0366(20)30261-3","article-title":"Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis","volume":"7","author":"Siskind","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"2026021206350880000_5.1.e002190.34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/15504263.2021.1944712","article-title":"Systematic Review of Psychosocial Smoking Cessation Interventions for People with Serious Mental Illness","volume":"17","author":"Hawes","year":"2021","journal-title":"J Dual Diagn"},{"key":"2026021206350880000_5.1.e002190.35","doi-asserted-by":"crossref","first-page":"102530","DOI":"10.1016\/j.ajp.2020.102530","article-title":"Non-pharmacological interventions for smoking in persons with schizophrenia spectrum disorders - A systematic review","volume":"56","author":"Rajalu","year":"2021","journal-title":"Asian J Psychiatr"},{"key":"2026021206350880000_5.1.e002190.36","unstructured":"Li T , Higgins JPT , Salanti G . Chapter 11: undertaking network meta-analyses. In: Higgins JT , Chandler J , Cumpston M , et al , eds. Cochrane Handbook for Systematic Reviews of Interventions (Version 6.5 2024). Cochrane, 2024. Available: www.cochrane.org\/handbook"},{"key":"2026021206350880000_5.1.e002190.37","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"2026021206350880000_5.1.e002190.38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026021206350880000_5.1.e002190.39","unstructured":"Guyatt G , Oxman A . Handbook for grading the quality of evidence and the strength of recommendations using the grade approach. 2013. Available: https:\/\/gdtgradeproorg\/app\/handbook"},{"key":"2026021206350880000_5.1.e002190.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081903","article-title":"Core GRADE 1: overview of the Core GRADE approach","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"2026021206350880000_5.1.e002190.41","article-title":"Smoking reduction interventions for smoking cessation","volume":"9","author":"Lindson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026021206350880000_5.1.e002190.42","unstructured":"London School of Hygiene and Tropical Medicine. 2018. Available: https:\/\/blogs.lshtm.ac.uk\/library\/2018\/12\/07\/removing-duplicates-from-an-endnote-library"},{"key":"2026021206350880000_5.1.e002190.43","unstructured":"Falconer J . Removing duplicates from an Endnote library, 2018. Available: https:\/\/blogslshtmacuk\/library\/2018\/12\/07\/removing-duplicates-from-an-endnote-library\/"},{"key":"2026021206350880000_5.1.e002190.44","unstructured":"Higgins JPT , Thomas J , Chandler J , et al , eds. Cochrane Handbook for Systematic Reviews of Interventions Version. 6.5 (updated August 2024).2024.Available: www.cochrane.org\/handbook"},{"key":"2026021206350880000_5.1.e002190.45","unstructured":"Guyatt GB . Methods Commentary: Risk of Bias in Randomized Trials.2021. Available: https:\/\/www.distillersr.com\/resources\/methodological-resources\/risk-of-bias-commentary"},{"key":"2026021206350880000_5.1.e002190.46","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1373"},{"key":"2026021206350880000_5.1.e002190.47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta\u2010analysis","volume":"3","author":"van Valkenhoef","year":"2012","journal-title":"Res Synth Methods"},{"key":"2026021206350880000_5.1.e002190.48","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-019-0829-2","article-title":"BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network Meta-analyses","volume":"19","author":"B\u00e9liveau","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"2026021206350880000_5.1.e002190.49","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v106.i02"},{"key":"2026021206350880000_5.1.e002190.50","unstructured":"R Core Team . R: a language and environment for statistical computing. 2024. Available: https:\/\/www.R-project.org"},{"key":"2026021206350880000_5.1.e002190.51","unstructured":"Cochrane Collaboration . 5. Review manager (revman), version 5.4. 2020.4. Available: https:\/\/www.cochrane.org\/learn\/courses-and-resources\/software"},{"key":"2026021206350880000_5.1.e002190.52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jad.2019.06.008","article-title":"Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial","volume":"256","author":"Heffner","year":"2019","journal-title":"J Affect Disord"},{"key":"2026021206350880000_5.1.e002190.53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00406-012-0338-3","article-title":"A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients","volume":"263","author":"Chen","year":"2013","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2026021206350880000_5.1.e002190.54","unstructured":"Survey . On minimal important difference for long-term abstinence. survey took place during the second panel meetings for BMJ RAPICREC on smoking cessation in SMI (13 and 15 May 2025 using teams software). 2025."},{"key":"2026021206350880000_5.1.e002190.55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/bmjebm-2020-111600","article-title":"Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression","volume":"27","author":"Hengartner","year":"2022","journal-title":"BMJ EBM"},{"key":"2026021206350880000_5.1.e002190.56","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07162"},{"key":"2026021206350880000_5.1.e002190.57","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m3900","article-title":"GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework","volume":"371","author":"Brignardello-Petersen","year":"2020","journal-title":"BMJ"},{"key":"2026021206350880000_5.1.e002190.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.10.005"},{"key":"2026021206350880000_5.1.e002190.59","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"2026021206350880000_5.1.e002190.60","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081904","article-title":"Core GRADE 2: choosing the target of certainty rating and assessing imprecision","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"2026021206350880000_5.1.e002190.61","unstructured":"Chairmani A , Caldwell DM , Li T , et al . 11.2.2 transitivity. In: Higgins JPT , Thomas J , Chandler J , eds. Cochrane Handbook for Systematic Reviews of Interventions version 6.5. 2024. Cochrane, 2024. Available: www.cochrane.org\/handbook"},{"key":"2026021206350880000_5.1.e002190.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.06.010"},{"key":"2026021206350880000_5.1.e002190.63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/da.23259","article-title":"The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial","volume":"39","author":"Cinciripini","year":"2022","journal-title":"Depress Anxiety"},{"key":"2026021206350880000_5.1.e002190.64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10865-019-00083-8","article-title":"Proactive outreach tobacco treatment for socioeconomically disadvantaged smokers with serious mental illness","volume":"43","author":"Hammett","year":"2020","journal-title":"J Behav Med"},{"key":"2026021206350880000_5.1.e002190.65","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1769"},{"key":"2026021206350880000_5.1.e002190.66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/da.22982","article-title":"Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial","volume":"37","author":"Ayers","year":"2020","journal-title":"Depress Anxiety"},{"key":"2026021206350880000_5.1.e002190.67","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.83"},{"key":"2026021206350880000_5.1.e002190.68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143490","article-title":"Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial","volume":"11","author":"Smith","year":"2016","journal-title":"PLoS One"},{"key":"2026021206350880000_5.1.e002190.69","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp116"},{"key":"2026021206350880000_5.1.e002190.70","article-title":"Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses","volume":"2023","author":"Lindson","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026021206350880000_5.1.e002190.71","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/add.14969","article-title":"Variability and effectiveness of comparator group interventions in smoking cessation trials: a systematic review and meta\u2010analysis","volume":"115","author":"Black","year":"2020","journal-title":"Addiction"},{"key":"2026021206350880000_5.1.e002190.72","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/add.14208","article-title":"Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES","volume":"113","author":"West","year":"2018","journal-title":"Addiction"},{"key":"2026021206350880000_5.1.e002190.73","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jcop.22197","article-title":"Reasons for smoking and barriers to cessation among adults with serious mental illness: A qualitative study","volume":"47","author":"Keller-Hamilton","year":"2019","journal-title":"J Community Psychol"},{"key":"2026021206350880000_5.1.e002190.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.06.007"},{"key":"2026021206350880000_5.1.e002190.75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04024.x"},{"key":"2026021206350880000_5.1.e002190.76","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f5704","article-title":"Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study","volume":"347","author":"Thomas","year":"2013","journal-title":"BMJ"},{"key":"2026021206350880000_5.1.e002190.77","unstructured":"FDA . FDA drug safety communication: FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings. 2015. Available: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-revises-description-mental-health-side-effects-stop-smoking"},{"key":"2026021206350880000_5.1.e002190.78","unstructured":"European Medicines Agency (EMA) . Champix Procedural Steps Taken and Scientific Information after the Authorization.2016. Available: http:\/\/wwwwebcitationorg\/6l0EAvMaR)"},{"key":"2026021206350880000_5.1.e002190.79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.amepre.2018.04.021","article-title":"Smoking Cessation for Smokers Not Ready to Quit: Meta-analysis and Cost-effectiveness Analysis","volume":"55","author":"Ali","year":"2018","journal-title":"Am J Prev Med"},{"key":"2026021206350880000_5.1.e002190.80","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/add.15671","article-title":"Comparison of saliva cotinine and exhaled carbon monoxide concentrations when smoking and after being offered dual nicotine replacement therapy in pregnancy","volume":"117","author":"Slaich","year":"2022","journal-title":"Addiction"},{"key":"2026021206350880000_5.1.e002190.81","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0626-2","article-title":"Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial","volume":"14","author":"Tulloch","year":"2016","journal-title":"BMC Med"},{"key":"2026021206350880000_5.1.e002190.82","article-title":"Nicotine replacement therapy for smoking cessation","volume":"11","author":"Stead","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026021206350880000_5.1.e002190.83","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"5","author":"Livingstone-Banks","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026021206350880000_5.1.e002190.84","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0395"},{"key":"2026021206350880000_5.1.e002190.85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40263-017-0438-8","article-title":"Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations","volume":"31","author":"Cather","year":"2017","journal-title":"CNS Drugs"},{"key":"2026021206350880000_5.1.e002190.86","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1176\/appi.ps.202000032","article-title":"Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES","volume":"72","author":"Evins","year":"2021","journal-title":"PS"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2025-002190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:35:25Z","timestamp":1770906925000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2025-002190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,12]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjmed-2025-002190"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2025-002190","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}